360iResearch Logo
Global Pediatric Vaccines Market
Report Code: MRR-4851569 | Publishing Date: August 2020 | Number of Pages: 238

The Global Pediatric Vaccines Market to grow from USD 12,943.26 Million in 2019 to USD 22,869.61 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 9.95%.

Market Segmentation & Coverage:

The research report categorizes the Pediatric Vaccines Market to forecast the revenues and analyze the trends in each of the following segments:

"The Conjugates is projected to witness the highest growth during the forecast period"

Based on Technology, the Pediatric Vaccines Market studied across Attenuated Live Viruses, Conjugates, Inactivated Viruses, Polysaccharides, Recombinant, Subunits, and Toxoids. The Attenuated Live Viruses commanded the largest size in the Pediatric Vaccines Market in 2019, followed by the Recombinant. On the other hand, the Conjugates expected to grow at the fastest CAGR during the forecast period, followed by the Recombinant.

"The Multivalent is projected to witness the highest growth during the forecast period"

Based on Vaccine Type, the Pediatric Vaccines Market studied across Monovalent and Multivalent. The Multivalent commanded the largest size in the Pediatric Vaccines Market in 2019, followed by the Monovalent. On the other hand, the Multivalent expected to grow at the fastest CAGR during the forecast period, followed by the Monovalent.

"The Pediatric Clinic is projected to witness the highest growth during the forecast period"

Based on End User, the Pediatric Vaccines Market studied across Hospital, Pediatric Clinic, and Research Organization. The Pediatric Clinic commanded the largest size in the Pediatric Vaccines Market in 2019, followed by the Hospital. On the other hand, the Pediatric Clinic expected to grow at the fastest CAGR during the forecast period, followed by the Hospital.

"The Haemophilus Influenzae Type B is projected to witness the highest growth during the forecast period"

Based on Indication, the Pediatric Vaccines Market studied across Haemophilus Influenzae Type B, Hepatitis, Human papillomavirus (HPV), Measles, Meningitis A, Mumps, Pneumococcal Diseases, Polio, Rotaviruses, Rubella, Tetanus, and Yellow Fever. The Pneumococcal Diseases commanded the largest size in the Pediatric Vaccines Market in 2019, followed by the Polio. On the other hand, the Haemophilus Influenzae Type B expected to grow at the fastest CAGR during the forecast period, followed by the Measles.

"The Asia-Pacific is projected to witness the highest growth during the forecast period"

Based on Geography, the Pediatric Vaccines Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Pediatric Vaccines Market in 2019, followed by the Americas. On the other hand, the Asia-Pacific expected to grow at the fastest CAGR during the forecast period, followed by the Europe, Middle East & Africa.

Market Dynamics:

The factors attributing to the growth of the market are government intervention for the use of pediatric vaccines, benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others, and increasing prevalence of infectious diseases in the pediatric population. However, some factors such as lack of implementation of mandatory vaccination and slight-side effects associated with pediatric vaccines may hinder the market growth. The Pediatric Vaccines Market expected to showcase the opportunities such as strong late-stage pipeline and new drug approvals and routinized vaccines used in immunization of infants and children. Soon market may face the possible challenges in the growth due to no uniform recall or reminder system and staff shortages. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch Competitive Strategic Window:

The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

360iResearch FPNV Positioning Matrix:

The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Pediatric Vaccines Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Company Usability Profiles:

The Pediatric Vaccines Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pediatric Vaccines Market, including AstraZeneca PLC, CSL Limited, Eli Lilly and Company, GlaxoSmithKline PLC, Merck Sharp & Dohme Corp., Mitsubishi Chemical Corporation, Novartis AG, Pfizer Inc., Sanofi S.A., and Serum Institute of India Pvt. Ltd..

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
      8. Repeat: Report Update
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
  3. Executive Summary
    1. Market Outlook
    2. Technology Outlook
    3. Vaccine Type Outlook
    4. End User Outlook
    5. Indication Outlook
    6. Geography Outlook
    7. Competitor Outlook
  4. Market Overview
    1. Introduction
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Increasing prevalence of infectious diseases in the pediatric population
      2. Benefits of immunizations like protection from serious diseases prevention and the spread of those diseases to others
      3. Government intervention for the use of pediatric vaccines
    3. Restraints
      1. Lack of implementation of mandatory vaccination
      2. Slight-side effects associated with pediatric vaccines
    4. Opportunities
      1. Strong late-stage pipeline and new drug approvals
      2. Routinized vaccines used in immunization of infants and children
    5. Challenges
      1. No uniform recall or reminder system and staff shortages
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
  7. Global Pediatric Vaccines Market, By Technology
    1. Introduction
    2. Attenuated Live Viruses
    3. Conjugates
    4. Inactivated Viruses
    5. Polysaccharides
    6. Recombinant
    7. Subunits
    8. Toxoids
  8. Global Pediatric Vaccines Market, By Vaccine Type
    1. Introduction
    2. Monovalent
    3. Multivalent
  9. Global Pediatric Vaccines Market, By End User
    1. Introduction
    2. Hospital
    3. Pediatric Clinic
    4. Research Organization
  10. Global Pediatric Vaccines Market, By Indication
    1. Introduction
    2. Haemophilus Influenzae Type B
    3. Hepatitis
    4. Human papillomavirus (HPV)
    5. Measles
    6. Meningitis A
    7. Mumps
    8. Pneumococcal Diseases
    9. Polio
    10. Rotaviruses
    11. Rubella
    12. Tetanus
    13. Yellow Fever
  11. Global Pediatric Vaccines Market, By Geography
    1. Introduction
    2. Americas
      1. Argentina
      2. Brazil
      3. Canada
      4. Mexico
      5. United States
    3. Asia-Pacific
      1. Australia
      2. China
      3. India
      4. Indonesia
      5. Japan
      6. Malaysia
      7. Philippines
      8. South Korea
      9. Thailand
    4. Europe, Middle East & Africa
      1. France
      2. Germany
      3. Italy
      4. Netherlands
      5. Qatar
      6. Russia
      7. Saudi Arabia
      8. South Africa
      9. Spain
      10. United Arab Emirates
      11. United Kingdom
  12. 360iResearch Competitive Strategic Window
    1. Introduction
    2. 360iResearch Competitive Strategic Window, by Technology
    3. 360iResearch Competitive Strategic Window, by Vaccine Type
    4. 360iResearch Competitive Strategic Window, by End User
    5. 360iResearch Competitive Strategic Window, by Indication
    6. 360iResearch Competitive Strategic Window, by Geography
  13. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. 360iResearch Market Ranking Analysis
    3. 360iResearch Market Share Analysis
    4. 360iResearch Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration, & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
      5. Award, Recognition, & Expansion
  14. Company Usability Profiles
    1. AstraZeneca PLC
    2. CSL Limited
    3. Eli Lilly and Company
    4. GlaxoSmithKline PLC
    5. Merck Sharp & Dohme Corp.
    6. Mitsubishi Chemical Corporation
    7. Novartis AG
    8. Pfizer Inc.
    9. Sanofi S.A.
    10. Serum Institute of India Pvt. Ltd.
  15. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ATTENUATED LIVE VIRUSES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY CONJUGATES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INACTIVATED VIRUSES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLYSACCHARIDES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RECOMBINANT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY SUBUNITS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TOXOIDS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  11. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MONOVALENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MULTIVALENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HOSPITAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PEDIATRIC CLINIC, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RESEARCH ORGANIZATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HAEMOPHILUS INFLUENZAE TYPE B, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  19. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HEPATITIS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY HUMAN PAPILLOMAVIRUS (HPV), BY GEOGRAPHY, 2017-2025 (USD MILLION)
  21. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MEASLES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MENINGITIS A, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  23. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY MUMPS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  24. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY PNEUMOCOCCAL DISEASES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  25. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY POLIO, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  26. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY ROTAVIRUSES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  27. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY RUBELLA, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  28. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TETANUS, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  29. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY YELLOW FEVER, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  30. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  31. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  32. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  33. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  34. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  35. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  36. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  37. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  38. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  39. ARGENTINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  40. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  41. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  42. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  43. BRAZIL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  44. CANADA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  45. CANADA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  46. CANADA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  47. CANADA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  48. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  49. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  50. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  51. MEXICO PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  52. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  53. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  54. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  55. UNITED STATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  56. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  57. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  58. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  59. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  60. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  61. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  62. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  63. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  64. AUSTRALIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  65. CHINA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  66. CHINA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  67. CHINA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  68. CHINA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  69. INDIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  70. INDIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  71. INDIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  72. INDIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  73. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  74. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  75. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  76. INDONESIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  77. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  78. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  79. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  80. JAPAN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  81. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  82. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  83. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  84. MALAYSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  85. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  86. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  87. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  88. PHILIPPINES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  89. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  90. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  91. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  92. SOUTH KOREA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  93. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  94. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  95. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  96. THAILAND PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  97. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  98. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  99. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  100. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  101. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  102. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  103. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  104. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  105. FRANCE PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  106. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  107. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  108. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  109. GERMANY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  110. ITALY PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  111. ITALY PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  112. ITALY PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  113. ITALY PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  114. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  115. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  116. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  117. NETHERLANDS PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  118. QATAR PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  119. QATAR PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  120. QATAR PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  121. QATAR PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  122. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  123. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  124. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  125. RUSSIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  126. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  127. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  128. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  129. SAUDI ARABIA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  130. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  131. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  132. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  133. SOUTH AFRICA PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  134. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  135. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  136. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  137. SPAIN PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  138. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  139. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  140. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  141. UNITED ARAB EMIRATES PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  142. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2017-2025 (USD MILLION)
  143. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2017-2025 (USD MILLION)
  144. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2017-2025 (USD MILLION)
  145. UNITED KINGDOM PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  146. GLOBAL PEDIATRIC VACCINES MARKET: SCORES
  147. GLOBAL PEDIATRIC VACCINES MARKET: BUSINESS STRATEGY
  148. GLOBAL PEDIATRIC VACCINES MARKET: PRODUCT SATISFACTION
  149. GLOBAL PEDIATRIC VACCINES MARKET: RANKING
  150. GLOBAL PEDIATRIC VACCINES MARKET: MERGER & ACQUISITION
  151. GLOBAL PEDIATRIC VACCINES MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  152. GLOBAL PEDIATRIC VACCINES MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  153. GLOBAL PEDIATRIC VACCINES MARKET: INVESTMENT & FUNDING
  154. GLOBAL PEDIATRIC VACCINES MARKET: AWARD, RECOGNITION, & EXPANSION
  155. GLOBAL PEDIATRIC VACCINES MARKET: EDITION DETAILS
  156. GLOBAL PEDIATRIC VACCINES MARKET: LICENSE DETAILS
  157. GLOBAL PEDIATRIC VACCINES MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL PEDIATRIC VACCINES MARKET: RESEARCH PROCESS
  2. GLOBAL PEDIATRIC VACCINES MARKET: RESEARCH EXECUTION
  3. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
  5. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2019 VS 2025 (USD MILLION)
  6. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
  7. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  8. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  9. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PEDIATRIC VACCINES MARKET, BY TYPE
  10. GLOBAL PEDIATRIC VACCINES MARKET SIZE, 2017-2025 (USD MILLION)
  11. GLOBAL PEDIATRIC VACCINES MARKET SIZE GROWTH, 2017-2025 (USD MILLION)
  12. GLOBAL PEDIATRIC VACCINES MARKET: MARKET DYNAMICS
  13. GLOBAL PEDIATRIC VACCINES MARKET: PORTERS FIVE FORCES ANALYSIS
  14. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2019 VS 2025 (USD MILLION)
  15. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2019 VS 2025 (USD MILLION)
  16. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2019 VS 2025 (USD MILLION)
  17. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  18. GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  19. AMERICAS PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  20. ASIA-PACIFIC PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  21. EUROPE, MIDDLE EAST & AFRICA PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY TECHNOLOGY, 2025
  23. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY VACCINE TYPE, 2025
  24. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY END USER, 2025
  25. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY INDICATION, 2025
  26. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PEDIATRIC VACCINES MARKET SIZE, BY GEOGRAPHY, 2025
  27. GLOBAL PEDIATRIC VACCINES MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  28. GLOBAL PEDIATRIC VACCINES MARKET: 360IRESEARCH MARKET SHARE ANALYSIS